NASDAQ:KERX

Insider Trading, NYSE, Markets, Stock Trader On The Phone

Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More

Singer’s Elliott Management Buys Sky Stake Ahead of Vote (Bloomberg) Elliott Management Corp., the hedge fund founded by billionaire Paul Singer......(read more)

January 29 - Hedge Funds, Insider Trading - Comments

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Best Healthcare Stocks: Billionaire Seth Klarman’s Picks

What are the best healthcare stocks to invest in? Baupost Group was founded in 1982 by Harvard Professor William Poorvu and partners Howard Stevenson,......(read more)

December 15 - Hedge Funds, News - Comments

doctor, patient, talking, man, male, physician, senior, older, consultant, medical, smiling, people, helpful, adult, desk, working, usa, american, practitioner, horizontal, taking

Do Hedge Funds Love Keryx Biopharmaceuticals Inc (KERX)?

Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking......(read more)

December 11 - Hedge Funds, News - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here Are Two Dates To Keep An Eye On In Biotech Across The Next Two Weeks

The fourth quarter of this year is set to be a big one in the biotech space, with a number of key development slated across October, November and December......(read more)

October 20 - News, Stock Analysis - Comments

Countries with the Smallest Government Per Capita in the World

A Closer Look at Five Stocks on the Move on Monday

U.S. stocks are mixed on Monday trading, as a spike in tech stocks countered the tumble in energy, driven by declining oil prices. Among the stocks registering......(read more)

August 1 - Earnings Report, News - Comments

virgin, australia, blue, mode, travel, mid-air, 737, business, locations, jet, people, vehicle, tasmania, transport, airplane, hobart, outdoors, transportation, tourism, airport,

Why These 5 Stocks Are Big Gainers Today

Even though oil continues to plummet, the market is rebounding on Tuesday, with all major U.S stock indexes trading up. Among the stocks driving said......(read more)

March 29 - Market Movers, News - Comments

Billionaire Seth Klarman’s Top Biotech Stock Picks

A high majority of hedge fund managers delivered a terrible performance in 2015 and widely-known value investor Seth Klarman was no exception. Baupost......(read more)

February 15 - Hedge Fund Analysis, Hedge Funds, News - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Hedge Funds Are Selling Keryx Biopharmaceuticals (KERX)

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Micron and Anadarko Petroleum, have not done well during......(read more)

December 5 - Hedge Funds, News - Comments

Four Hot Biotechs Among The Day’s Big Winners

On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks......(read more)

October 19 - Market Movers, News - Comments

Why Are An Indian Automaker and Two Biotech Stocks Leading Today’s Gainers?

Key bank earnings and economic data have reinvigorated the U.S stock market today. The Consumer Price Index and initial jobless claims data were better......(read more)

October 15 - Market Movers, News - Comments

What Happened To Billionaire Seth Klarman’s Top Biotech Picks In The Third Quarter?

Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman’s $31 billion fund, Baupost Group, has achieved......(read more)

October 14 - News - Comments

Two Biotech Stocks Have Been Ignoring the Crowd Today and This Metric Says They are Poised to Grow Even Further

Amid a broader market sell-off, several biotechnology stocks have surged in today’s trading session, although the industry overall has declined with......(read more)

September 24 - Hedge Funds, Market Movers, News - Comments

Billionaire Klarman’s Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy

The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman. Klarman’s fund is one of the biggest and most successful......(read more)

May 22 - Hedge Funds, News - Comments

Billionaire Seth Klarman’s Biotech Stock Picks

Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns. He founded Baupost Group......(read more)

March 15 - Hedge Funds, News - Comments

Keryx Biopharmaceuticals (KERX): Baupost Group Boosts Its Stake

Seth Klarman is bullish on Keryx Biopharmaceuticals (NASDAQ:KERX) and his fund, Baupost Group, has recently surged its position in the company. As a......(read more)

October 10 - Hedge Funds, News - Comments

Seth Klarman’s Baupost Group Continues to Bet on Tech

On Wednesday, May 14th, Seth Klarman’s Baupost Group, presented its Form 13F Filing for the first quarter of 2014 at the U.S. Securities and Exchange......(read more)

May 15 - Hedge Funds - Comments

Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)

What’s a smart Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) investor to do? In the 21st century investor’s toolkit, there are dozens of indicators......(read more)

September 17 - News - Comments

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation

Think of The Motley Fool as kind of your TiVo for investment conferences. We’ll help you skip to the good parts and zip past all the rest. There......(read more)

September 15 - News - Comments

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund......(read more)

September 13 - News - Comments

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to......(read more)

September 4 - News - Comments

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail

Drugs fail their clinical trials for all kinds of reasons. Sometimes, it’s related to efficacy; sometimes, it’s safety related. Most of the......(read more)

August 30 - News - Comments

Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools......(read more)

August 30 - News - Comments

Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday. Shares fell slightly as investors reacted......(read more)

August 1 - News - Comments

ExOne Co (XONE), MannKind Corporation (MNKD): Here’s What This $30 Billion Pension Fund Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

July 29 - News - Comments

Solta Medical Inc (SLTM), Keryx Biopharmaceuticals (KERX): Two Stocks to Buy on Merger Speculation

Large healthcare companies are facing revenue declines due to expiring patents. These cash rich giants are increasingly investing in small biotechnology......(read more)

July 25 - News - Comments

Keryx Biopharmaceuticals (KERX): Rare Diseases and Rare Drugs Could Mean Great Gains For You

The U.S. is the largest market of biotechnology products in the world. There are more than 1,300 companies involved in the research and development of......(read more)

July 18 - News - Comments

Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?

Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......(read more)

July 12 - News - Comments

Hedge Funds Are Buying Endocyte, Inc. (ECYT)

Is Endocyte, Inc. (NASDAQ:ECYT) a marvelous investment today? The best stock pickers are in a bullish mood. The number of long hedge fund positions inched......(read more)

June 17 - News - Comments

Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)

Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds’ portfolio at the end of March. KYTH investors should be aware of an increase......(read more)

June 14 - News - Comments

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 16 hedge funds’ portfolio at the end of March. ASTX investors should be aware of an increase in......(read more)

June 12 - News - Comments

Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. NBIX has experienced an increase......(read more)

June 6 - News - Comments

Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors should pay attention to an increase in hedge fund interest in recent months. According to most shareholders......(read more)

June 4 - News - Comments

Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)

Keryx Biopharmaceuticals (NASDAQ:KERX) investors should pay attention to an increase in enthusiasm from smart money in recent months. In today’s marketplace......(read more)

June 3 - News - Comments

Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

May 31 - Hedge Funds - Comments

Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX): Biotech Investing for Beginners

Huge fortunes are won and lost in the world of biotech nearly every week. For those new to this world, it can appear both alluring and scary. Biotech......(read more)

May 22 - News - Comments

Trenders’ News: Caterpillar Inc. (CAT) Falls Short, Microsoft Corporation (MSFT) Mega-Boost and More

Editor’s Note: Related tickers: Caterpillar Inc. (NYSE:CAT), Microsoft Corporation (NASDAQ:MSFT), Keryx Biopharmaceuticals (NASDAQ:KERX), Halliburton......(read more)

April 22 - News - Comments

Is Keryx Biopharmaceuticals (KERX) Going to Burn These Hedge Funds?

Keryx Biopharmaceuticals (NASDAQ:KERX) was in 6 hedge funds’ portfolio at the end of December. KERX investors should pay attention to a decrease......(read more)

April 18 - News - Comments

Pharmacyclics, Inc. (PCYC), Keryx Biopharmaceuticals (KERX): These Cutting-Edge Science Stocks Are Soaring

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some biotech and genome-focused......(read more)

April 16 - News - Comments

Endocyte, Inc. (NASDAQ:ECYT), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH): Should You Avoid Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)?

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a safe stock to buy now? Prominent investors are in a bearish mood. The number of long hedge fund bets dropped......(read more)

April 4 - News - Comments

Sarepta Therapeutics Inc (SRPT), Keryx Biopharmaceuticals (KERX), MannKind Corporation (MNKD): Three Speculative Biotech Companies Primed to Pop

They don’t have any products on the market. They have little or no revenue. Earnings? Nada. Many people are betting that they will fail. And yet......(read more)

April 4 - News - Comments

Pitney Bowes Inc. (PBI), Cirrus Logic, Inc. (CRUS), Keryx Biopharmaceuticals (KERX): Here’s What This $3 Billion Market Wizard Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a bright light......(read more)

April 1 - News - Comments

Amarin Corporation plc (ADR) (AMRN), Exelixis, Inc. (EXEL): Here’s What This 220% Gainer Has Been Buying and Selling

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

March 20 - Hedge Funds - Comments

Dynavax Technologies Corporation (NASDAQ:DVAX)

3 Biotechs Still Burning Through Cash: Ariad Pharmaceuticals, Inc. (ARIA), Dynavax Technologies Corporation (DVAX), MannKind Corporation (MNKD)

Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue. Thanks......(read more)

March 5 - News - Comments

Posts Tagged ‘NASDAQ:KERX’